-
Noureddin M, Truong E, Mayo R, Martínez-Arranz I, Mincholé I, Banales JM, Arrese M, Cusi K, Arias-Loste MT, Bruha R, Romero-Gómez M, Iruzubieta P, Aller R, Ampuero J, Calleja JL, Ibañez-Samaniego L, Aspichueta P, Martín-Duce A, Kushner T, Ortiz P, Harrison SA, Anstee QM, Crespo J, Mato JM, Sanyal AJ.
Serum identification of at-risk MASH: The metabolomics-advanced steatohepatitis fibrosis score (MASEF)
Hepatology.,
2024
-
Aspichueta P, Zeisel MB.
miR-21p-5p coordinates biological pathways to promote MASLD progression
Liver Int.,
2023
-
Marsal-Beltran A, Rodríguez-Castellano A, Astiarraga B, Calvo E, Rada P, Madeira A, Rodríguez-Peña MM, Llauradó G, Núñez-Roa C, Gómez-Santos B, Maymó-Masip E, Bosch R, Frutos MD, Moreno-Navarrete JM, Ramos-Molina B, Aspichueta P, Joven J, Fernández-Real JM, Quer JC, Valverde ÁM, Pardo A, Vendrell J, Ceperuelo-Mallafré V, Fernández-Veledo S.
Protective effects of the succinate/SUCNR1 axis on damaged hepatocytes in NAFLD
Metabolism.,
2023
-
Manka P, Coombes JD, Sydor S, Swiderska-Syn MK, Best J, Gauthier K, van Grunsven LA, Oo YH, Wang C, Diehl AM, Hönes GS, Moeller LC, Figge A, Boosman RJ, Faber KN, Tannapfel A, Goetze O, Aspichueta P, Lange CM, Canbay A, Syn WK.
Thyroid hormone receptor alpha modulates fibrogenesis in hepatic stellate cells
Liver Int.,
2024
-
Aurrekoetxea I, Gomez-Santos B, Apodaka-Biguri M, Ruiz de Gauna M, Gonzalez-Romero F, Buqué X, Aspichueta P.
In Vivo Tissue Lipid Uptake in Antisense Oligonucleotide (ASO)-Treated Mice
Methods Mol Biol.,
2023
-
Gomez-Santos B, Saenz de Urturi D, Buqué X, Aurrekoetxea I, Nieva A, Fernández-Puertas I, Aspichueta P.
In Vivo Hepatic Triglyceride Secretion Rate in Antisense Oligonucleotide (ASO)-Treated Mice
Methods Mol Biol.,
2023
-
Saliba-Gustafsson P, Justesen JM, Ranta A, Sharma D, Bielczyk-Maczynska E, Li J, Najmi LA, Apodaka M, Aspichueta P, Björck HM, Eriksson P, Franco-Cereceda A, Gloudemans M, Mujica E, den Hoed M, Assimes TL, Quertermous T, Carcamo-Orive I, Park CY, Knowles JW.
A functional genomic framework to elucidate novel causal non-alcoholic fatty liver disease genes
medRxiv,
2023
-
Begoña Lavin, Thomas R Eykyn, Alkystis Phinikaridou, Aline Xavier, Shravan Kumar, Xabier Buqué, Patricia Aspichueta, Carlos Sing-Long, Marco Arrese, René M Botnar, Marcelo E Andia
Characterization of hepatic fatty acids using Magnetic Resonance Spectroscopy for the assessment of treatment response to Metformin in an eNOS-/- mouse model of metabolic NAFLD-NASH
NMR Biomed,
2023
-
Ruben Nogueiras, Patricia Aspichueta
Expanding the roles of the renin-angiotensin system: Drug-induced liver injury
J Hepatol,
2023
-
Marta Martín-Fernández, Víctor Arroyo, Carmen Carnicero, Rebeca Sigüenza, Reyes Busta, Natalia Mora, Beatriz Antolín, Eduardo Tamayo, Patricia Aspichueta, Irene Carnicero-Frutos, Hugo Gonzalo-Benito, Rocío Aller
Role of Oxidative Stress and Lipid Peroxidation in the Pathophysiology of NAFLD
Antioxidants (Basel),
2022
-
Mohaddase Hamidi, Ainhoa Eriz, Jone Mitxelena, Larraitz Fernandez-Ares, Igor Aurrekoetxea, Patricia Aspichueta, Ainhoa Iglesias-Ara, Ana M Zubiaga
Targeting E2F Sensitizes Prostate Cancer Cells to Drug-Induced Replication Stress by Promoting Unscheduled CDK1 Activity
Cancers (Basel),
2022
-
Ibone Labiano, Aloña Agirre-Lizaso, Paula Olaizola, Anne Echebarria, Maider Huici-Izagirre, Irene Olaizola, Aitor Esparza-Baquer, Omar Sharif, Elizabeth Hijona, Piotr Milkiewicz, Malgorzata Milkiewicz, Francisco González-Romero, Patricia Aspichueta, Maria J Monte, Jose J G Marin, Mihael Vucur, Tom Luedde, Marco Marzioni, Derek A Mann, Luis Bujanda, Pedro M Rodrigues, Jesus M Banales, Maria J Perugorria
TREM-2 plays a protective role in cholestasis by acting as a negative regulator of inflammation
J Hepatol,
2022
-
Paula Olaizola, Pedro M Rodrigues, Francisco J Caballero-Camino, Laura Izquierdo-Sanchez, Patricia Aspichueta, Luis Bujanda, Nicholas F Larusso, Joost P H Drenth, Maria J Perugorria, Jesus M Banales
Genetics, pathobiology and therapeutic opportunities of polycystic liver disease
Nat Rev Gastroenterol Hepatol,
2022
-
Paula Olaizola, Pui Yuen Lee-Law, Maite G Fernandez-Barrena, Laura Alvarez, Massimiliano Cadamuro, Mikel Azkargorta, Colm J O'Rourke, Francisco J Caballero-Camino, Irene Olaizola, Rocio I R Macias, Jose J G Marin, Marina Serrano-Maciá, Maria L Martinez-Chantar, Matias A Avila, Patricia Aspichueta, Diego F Calvisi, Matthias Evert, Luca Fabris, Rui E Castro, Felix Elortza, Jesper B Andersen, Luis Bujanda, Pedro M Rodrigues, Maria J Perugorria, Jesus M Banales
Targeting NAE1-mediated protein hyper-NEDDylation halts cholangiocarcinogenesis and impacts on tumor-stroma crosstalk in experimental models
J Hepatol,
2022
-
Gastaca M, Ruiz P, Bustamante J, Martinez-Indart L, Ventoso A, Fernandez JR, Palomares I, Prieto M, Testillano M, Salvador P, Senosiain M, Suárez MJ, Valdivieso A.
Early tacrolimus exposure does not impact long-term outcomes after liver transplantation
World J Hepatol,
2021;
13(3),
362 - 374
-
Perfecto A, Gastaca M, Prieto M, Cervera J, Ruiz P, Ventoso A, Palomares I, García JM, Valdivieso A.
Totally laparoscopic simultaneous resection of colorectal cancer and synchronous liver metastases: a single-center case series
Surg Endosc,
2021
-
Prieto M, Gastaca M, Ruiz P, Ventoso A, Palomares I, Rodríguez-Álvarez RJ, Salvador P, Bustamante J, Valdivieso A.
A case of COVID-19 immediately after liver transplantation: Not only bad news
Ann Hepatobiliary Pancreat Surg,
2020;
24(3),
314 - 318
-
Gastaca M, Gomez J, Terreros I, Izquierdo J, Ruiz P, Prieto M, Ventoso A, Palomares I, Aguinaga A, Valdivieso A.
Endovascular Therapy of Arterial Complications Within the First Week After Liver Transplant
Transplant Proc,
2020;
52(5),
1464 - 1467
-
Gastaca M, Prieto M, Palomares I, Bustamante J, Fernandez JR, Ruiz P, Ventoso A, Salvador P, Senosiain M, Testillano M, Suarez MJ, Valdivieso A.
Long-Term Outcomes of Liver Transplantation in Patients With Pretransplant Renal Dysfunction Treated With Induction Therapy and Delayed Reduced De Novo Once-Daily Tacrolimus
Transplant Proc,
2020;
52(5),
1489 - 1492
-
Prieto M, Gastaca M, Ruiz P, Ventoso A, Palomares I, Perfecto A, Valdivieso A.
Long term recurrence free survival in a stage IV gallbladder cancer treated with chemotherapy plus trastuzumab and salvage liver resection
Ann Hepatobiliary Pancreat Surg,
2019;
23(4),
403 - 407